期刊文献+

白藜芦醇抗柯萨奇病毒感染性小鼠心肌炎的实验研究 被引量:2

Effect of resveratrol on Coxsackie virus B3-induced myocarditis in mice
下载PDF
导出
摘要 目的 :研究白藜芦醇抗柯萨奇病毒感染性小鼠心肌炎的干预作用并探计其作用机理。方法 :对Balb/c小鼠采用柯萨奇病毒CVB3腹腔内注射染毒 ,制作病毒感染性心肌炎小鼠动物实验模型 ,采用黄芪煎液作为中药治疗对照 ,观察白藜芦醇饮水经口给药对模型小鼠的一般情况、生存率、肝脾大体及血清丙二醛(MDA)、一氧化氮 (NO)等生化指标及心脏组织病理学的影响。结果 :与黄芪煎液中药治疗对照相比 ,白藜芦醇对柯萨奇病毒感染性心肌炎小鼠的一般情况、生存率、心肝脾大体及血清丙二醛 (MDA)、一氧化氮(NO)等生化指标及心脏组织病理学均有良好的改善作用。结论 :白藜芦醇对柯萨奇病毒感染性小鼠心肌炎有良好的拮抗作用 ,对病毒性心肌炎的防治有一定意义。 Aim:To study the effect of resveratrol on Coxsackie virus B3-induced myocarditis in mice and its mechanism.Methods:Balb/c mice were injected intraperitonealy with Coxsackie virus B3.Control mice were treated with Astragalan after injection of Coxsackie virus B3. Resveratrol was resolved in water and given po. The general condition was observed. The survival rate, the weight of heart, liver and spleen, and level of MDA and NO in serum were measured. The histological changes of heart were examined. Results:Compared with Astragalan-treated group, the general condition and histological changes of heart were improved; the survival rate was increased; the weight of heart, liver, and spleen and the level of MDA and NO were decreased in the resveratrol-treated group. Conclusion:Resveratrol can prevent myocardium against Coxsackie virus B3 infection in mice and is useful in therapy of virus-induced myocarditis.
出处 《上海医药》 CAS 2003年第8期373-376,共4页 Shanghai Medical & Pharmaceutical Journal
关键词 白藜芦醇 柯萨奇病毒感染 心肌炎 丙二醛 一氧化氮 Coxsackie virus Balb/c mice animal model of mycocarditis resveratrol Astragalan effect of therapy
  • 相关文献

参考文献10

  • 1Soleas GJ, Diamandis EP, Goldberg DM. The world of resveratrol. Adv Exp Med Biol, 2001,492:159.
  • 2Docherty JJ, Fu MM, Stiffler BS,et al. Resveratrol inhibition of herpes simplex virus replication. Antiviral Res, 1999,43 ( 3 ) :145.
  • 3Fauconneau B, Waffo - Teguo P, Huguet F, et al. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests.Life Sci, 1997,61 (21) :2103.
  • 4Huber M, Selinka HC, Kandolf R. Tyrosine phosphorylafion events during coxsackievirus B3 replication. J Virol, 1997,71 ( 1 ) :595.
  • 5Liu P, Penninger J, Aitken K, et al. The role of transgenic knockout models in defining the pathogenesis of viral heart disease. Eur Heart J, 1995(16 Suppl O) :25.
  • 6Liu P, Aitken K, Kong Y-Y, et al. The tyrosine kinase p561ck is essential in coxsackievirus B3 - mediated heart disease. Nat Med,2000,6(4) :429.
  • 7Opavsky MA, Martino T, Rabinovitch M ,et al. Enhanced ERK -1/2 activation in mice susceptible to coxsackievirus -induced myocarditis. J Clin Invest, 2002,109(12) :1561.
  • 8Jayatilake GS, Jayasuriya H, Lee ES, et al. Kinase inhibitors from Polygonum cuspidatum. J Nat Prod, 1993,56(10) : 1805.
  • 9Yu R, Hebbar V, Kim DW,et al. Resveratrol inhibits phorbol ester and UV - induced activator protein 1 activation by interfering with mitogen -activated protein kinase pathways. Mol Pharmacol,2001,60(1) :217.
  • 10Gusman J, Malonne H, Atassi G. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol.Carcinogenesis, 2001,22 ( 8 ) : 1111.

同被引文献55

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部